Survival Benefits from Follow-Up of Patients with Lung Cancer: A Systematic Review and Meta-Analysis

Introduction: The burden of lung cancer is high for patients and carers. Care after treatment may have the potential to impact on this. We reviewed the published literature on follow-up strategies intended to improve survival and quality of life. Methods: We systematically reviewed studies comparing follow-up regimes in lung cancer. Primary outcomes were overall survival (comparing more intensive versus less intensive follow-up) and survival comparing symptomatic with asymptomatic recurrence. Quality of life was identified as a secondary outcome measure. Hazard ratios (HRs) and 95% confidence intervals from eligible studies were synthesized. Results: Nine studies that examined the role of more intensive follow-up for patients with lung cancer were included (eight observational studies and one randomized controlled trial). The studies of curative resection included patients with non-small cell lung cancer Stages I to III disease, and studies of palliative treatment follow-up included limited and extensive stage patients with small cell lung cancer. A total of 1669 patients were included in the studies. Follow-up programs were heterogeneous and multifaceted. A nonsignificant trend for intensive follow-up to improve survival was identified, for the curative intent treatment subgroup (HR: 0.83; 95% confidence interval: 0.66–1.05). Asymptomatic recurrence was associated with increased survival, which was statistically significant HR: 0.61 (0.50–0.74) (p < 0.01); quality of life was only assessed in one study. Conclusions: This meta-analysis must be interpreted with caution due to the potential for bias in the included studies: observed benefit may be due to systematic differences in outcomes rather than intervention effects. Some benefit was noted from intensive follow-up strategies. More robust data, in the form of randomized controlled trials, are needed to confirm these findings as the review is based primarily on observational studies. Future research should also include patient-centered outcomes to investigate the impact of follow-up regimes on living with lung cancer and psychosocial well-being.

[1]  Alona Muzikansky,et al.  Early palliative care for patients with metastatic non-small-cell lung cancer. , 2010, The New England journal of medicine.

[2]  E. Felip,et al.  Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  E. Felip,et al.  Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  P. Lambin,et al.  18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation. , 2010, European journal of cancer.

[5]  Murielle Mauer,et al.  Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials. , 2009, The Lancet. Oncology.

[6]  J. Ioannidis,et al.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration , 2009, BMJ : British Medical Journal.

[7]  J. Ioannidis,et al.  The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration , 2009, Annals of Internal Medicine [serial online].

[8]  P. Lambin,et al.  Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study. , 2009, European journal of cancer.

[9]  Malcolm Campbell,et al.  Comparing hospital and telephone follow-up after treatment for breast cancer: randomised equivalence trial , 2009, BMJ : British Medical Journal.

[10]  M. Adachi,et al.  Effectiveness of intensive follow-up after response in patients with small cell lung cancer. , 2008, Lung cancer.

[11]  J. Rubins,et al.  Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). , 2007, Chest.

[12]  Anthony J Alberg,et al.  Epidemiology of lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.

[13]  I. Park,et al.  Long-term survival following pneumonectomy for non-small cell lung cancer: clinical implications for follow-up care. , 2007, Chest.

[14]  M. Sydes,et al.  Practical methods for incorporating summary time-to-event data into meta-analysis , 2007, Trials.

[15]  M. Woronoff-Lemsi,et al.  Protocole IFCT-0302 : essai randomisé de deux schémas de surveillance dans les cancers bronchiques non à petites cellules complètement réséqués , 2007 .

[16]  F. Shepherd,et al.  Does Intensive Follow-up Alter Outcome in Patients with Advanced Lung Cancer? , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[17]  John Fletcher,et al.  What is heterogeneity and is it important? , 2007, BMJ : British Medical Journal.

[18]  N. Aziz.  Cancer survivorship research: State of knowledge, challenges and opportunities , 2007, Acta oncologica.

[19]  B. Milleron,et al.  [IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]. , 2007, Revue des maladies respiratoires.

[20]  M. Peat,et al.  Nurse and physiotherapy led follow-up for lung cancer patients after surgery , 2006 .

[21]  K. Cox,et al.  Preferences for Follow-up After Treatment for Lung Cancer: Assessing the Nurse-led Option , 2006, Cancer nursing.

[22]  A. Barrett,et al.  Optimization of follow-up timing from study of patterns of first failure after primary treatment. An example from patients with NSCLC: a study of the REACT working group of ESTRO. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  A. Dhar,et al.  National Institute for Health and Clinical Excellence , 2005 .

[24]  B Rachet,et al.  Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001 , 2004, British Journal of Cancer.

[25]  H. Pichlmaier,et al.  Die Effektivität schematisierter Nachsorgeuntersuchungen nach Resektion eines nichtkleinzelligen Bronchialkarzinoms , 2004, Langenbecks Archiv für Chirurgie.

[26]  P. Postmus,et al.  Consensus: the follow-up of the treated patient. , 2003, Lung cancer.

[27]  K. Cox,et al.  Follow-up for people with cancer: nurse-led services and telephone interventions. , 2003, Journal of advanced nursing.

[28]  Thomas J. Smith.  Evidence-based follow-up of lung cancer patients. , 2003, Seminars in Oncology.

[29]  B. Stewart,et al.  World Cancer Report , 2003 .

[30]  Peter Davey,et al.  A checklist for retrospective database studies--report of the ISPOR Task Force on Retrospective Databases. , 2003, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[31]  J. Rubins,et al.  Follow-up and surveillance of the lung cancer patient following curative-intent therapy. , 2003, Chest.

[32]  C. Normand,et al.  Nurse led follow up and conventional medical follow up in management of patients with lung cancer: randomised trial , 2002, BMJ : British Medical Journal.

[33]  M. Solèr,et al.  Regular follow-up after curative resection of nonsmall cell lung cancer: a real benefit for patients? , 2002, European Respiratory Journal.

[34]  J. Adlard,et al.  Open access follow-up for lung cancer: patient and staff satisfaction. , 2001, Clinical oncology (Royal College of Radiologists (Great Britain)).

[35]  Ali Montazeri,et al.  Quality of life in lung cancer patients: as an important prognostic factor. , 2001, Lung cancer.

[36]  A. Depierre,et al.  Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. , 2000, The Annals of thoracic surgery.

[37]  S J Pocock,et al.  Randomized trials or observational tribulations? , 2000, The New England journal of medicine.

[38]  S. Gilbert,et al.  Who should follow up lung cancer patients after operation? , 2000, The Annals of thoracic surgery.

[39]  R. Stephens,et al.  Depression in patients with lung cancer: prevalence and risk factors derived from quality-of-life data. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  M. Cooley,et al.  Symptoms in adults with lung cancer. A systematic research review. , 2000, Journal of pain and symptom management.

[41]  D. Deheinzelin,et al.  Follow-up in lung cancer: how often and for what purpose? , 1999, Chest.

[42]  M. Parmar,et al.  Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.

[43]  G. Smith,et al.  Meta-analysis Spurious precision? Meta-analysis of observational studies , 1998, BMJ.

[44]  K. Naunheim,et al.  Cost of patient follow-up after potentially curative lung cancer treatment. , 1996, The Journal of thoracic and cardiovascular surgery.

[45]  A. Auvinen,et al.  Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. , 1996, Journal of pain and symptom management.

[46]  K. Naunheim,et al.  Post‐Treatment Management Options for Patients with Lung Cancer , 1995, Annals of surgery.

[47]  M. O'connor,et al.  Is follow-up of lung cancer patients after resection medically indicated and cost-effective? , 1995, The Annals of thoracic surgery.

[48]  J. Müller,et al.  [The effectiveness of standardized follow-up studies after resection of non-small cell bronchial carcinoma]. , 1994, Langenbecks Archiv fur Chirurgie.

[49]  D. Osoba,et al.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.

[50]  C. Moinpour,et al.  A randomized clinical trial of home nursing care for lung cancer patients , 1989, Cancer.

[51]  E. Bergstralh,et al.  Postsurgical stage I bronchogenic carcinoma: morbid implications of recurrent disease. , 1984, The Annals of thoracic surgery.

[52]  E. Vellenga,et al.  HOMOZYGOUS α2-ANTIPLASMIN DEFICIENCY , 1979, The Lancet.

[53]  T. Shields,et al.  Long-term survivors after resection of lung carcinoma. , 1978, The Journal of thoracic and cardiovascular surgery.

[54]  F. Nelemans.  Follow-up examinations after operation for lung cancer. , 1973, Lancet.